Celularity
CELU
37 hedge funds and large institutions have $2.05M invested in Celularity in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 8 closing their positions.
1.47% less ownership
Funds ownership: 1.9% → 0.43% (-1.5%)
18% less funds holding
Funds holding: 45 → 37 (-8)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
74% less capital invested
Capital invested by funds: $8.02M → $2.05M (-$5.97M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$65.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.8K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.09K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$163 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.04M |
| 2 |
Millennium Management
New York
|
-$157K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
-$27.7K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$13.9K |
| 5 |
Morgan Stanley
New York
|
-$6.27K |
CELU Hedge Fund Activity: Q4 2023 in Review
37 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2023, worth a combined $2.05M — down 74% from $8.02M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CELU and 2 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $65.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.04M sold.
- 37 institutional investors held Celularity (CELU) as of Q4 2023, down from 45 in Q3 2023.
- Funds reported $2.05M of Celularity stock for Q4 2023, down 74% quarter-over-quarter.
- 2 funds opened new Celularity positions in Q4 2023 and 8 closed out, a net change of -6 holders.
- The largest Celularity buyer in Q4 2023 was Renaissance Technologies, an estimated $65.2K added.
- The largest Celularity seller in Q4 2023 was Armistice Capital, an estimated $1.04M sold.
Based on aggregated 13F filings for Q4 2023.